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Objectives: Optimal treatment strategies for patients with ischemic cardiomyopathy and moderately reduced left
ventricular function remain controversial. We assessed the early and midterm outcomes after surgical revascular-
ization alone versus revascularization and additional left ventricular remodeling in these patients.
Methods: Between 2000 and 2003, 285 consecutive patients with coronary artery disease and moderately im-
paired left ventricular function (ejection fraction 30%–40%) were surgically treated with coronary artery bypass
grafting alone (group 1, n ¼ 165) or open left ventricular remodeling in addition to revascularization (group 2,
n¼ 120). Preoperatively, the New York Heart Association class, left ventricular ejection fraction, and end-diastolic
diameter were comparable. Early and midterm outcomes, hemodynamic performance, and quality of life assessed
by Minnesota Quality of Life Questionnaire were evaluated during a mean follow-up period of 70 months.
Results: Group 2 patients demonstrated significantly longer ventilation times, higher blood loss, and need for
blood transfusion but had significantly lower operative mortality (4.5% compared with 8.5% in group 1).
Seven-year follow-up demonstrated survival of 74.3%  8.1% in group 1 versus 84.2%  5.4% in group 2
(P< .05). Follow-up examinations revealed greater improvement of functional class in group 1 with mean
1.7  0.7 versus 2.03  0.8 in group 2 (P< .05). Cardiac-related hospital readmissions were comparable
(3.8% vs 4.1%, P ¼ .73).
Conclusions: Patients with ischemic cardiomyopathy, in whom surgical ventricular remodeling was possible and
performed, experienced more perioperative complications but had superior early and midterm outcome regarding
survival, functional class, and quality of life.
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Coronary artery bypass grafting (CABG) has been estab-
lished as standard therapy for patients with advanced coro-
nary artery disease (CAD).1 It has also been extended to
patients with ischemic cardiomyopathy, even though im-
paired left ventricular (LV) function has been shown to ad-
versely affect early and late survival after CABG, especially
in patients with heart failure.2-4 Survival rates decline in re-
lation to the severity of LV dysfunction.
Surgical LV restoration in treatment of heart failure asso-
ciated with ischemic ventricular dilatation has been shown to
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toms, with excellent 5-year outcomes.5 Many of those re-
ports deal with surgical restoration of severely impaired
LV reflected by an LV ejection fraction (LVEF) of less
than 30% and/or severely dilated left ventricles (LV end-
systolic volume index greater than 100 mL/m2). Yamaguchi
and colleagues6 reported 5-year survival following isolated
CABG as low as 53% in these high-risk patients. Additional
LV restoration led to a significant increase of survival at 5
years up to 90% in the same patient group.7
Due to the superior results, LV restoration procedures
have become standard of care in patients with severely im-
paired ventricular function and ventricular dilatation espe-
cially if postinfarct aneurysm formation is demonstrated
either by echocardiography, magnetic resonance imaging
scanning, or angiography. However, optimal treatment strat-
egies for patients with ischemic cardiomyopathy and only
moderate LV dysfunction remain controversial.8,9 With re-
spect to the available literature on this issue, there is scarcity
of reports on the outcomes of combined LV restoration with
CABG in patients with ischemic cardiomyopathy and mod-
erate LV dysfunction.
The following retrospective study aims to assess the early
and midterm outcomes after surgical revascularization alone
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CABG ¼ coronary artery bypass grafting
CAD ¼ coronary artery disease
LV ¼ left ventricular
LVEF ¼ left ventricular ejection fraction
NYHA ¼ New York Heart Association
patients with ischemic cardiomyopathy and moderately re-
duced LV function.
PATIENTS AND METHODS
For purposes of this study, we analyzed medical records from all patients
with chronic stable CAD and ischemic cardiomyopathy (LVEF
30%–40%), who had operative treatment in our department between March
2000 and May 2003. A total of 285 patients meeting these criteria were in-
cluded in the study and further divided into 2 groups depending on whether
a surgical restoration of the impaired LV was not performed (group 1,
n ¼ 165) or performed (group 2, n ¼ 120) in addition to CABG.
Patients with acute preoperative ischemia-related heart failure requiring
inotropic support or intra-aortic counterpulsation were excluded from this
report. We also did not include patients having redo operations or a concom-
itant aortic valve procedure.
This retrospective study did not require approval by the Institutional Re-
view Board, as all operative techniques used were considered as established
standards.
Patients
Moderate ischemic cardiomyopathy was defined as at least coronary 2-
vessel disease and LVEF of 30% to 40% and symptoms of heart failure cor-
responding to New York Heart Association (NYHA) functional class III or
IV as recommended.10
The preoperative patient demographics are displayed in Table 1. Patients in
both groups did not significantly differ except that group 1 had a higher rate of
chronic obstructive pulmonary disease and systemic hypertension and group 2
had a higher preoperative cerebrovascular event rate. The majority of patients
presented with 3-vessel disease and history of previous myocardial infarction,
mostly located at the anterior wall. All patients were in NYHA functional class
III or IV. Preoperative NYHA class, LVEF, and end-diastolic diameter were
comparable between the 2 groups (3.2  0.6, 37.7%  112%, and 64.1 
7.3 mm, respectively, in group 1 vs 3.1  0.6, 38.9%  12.1%, and 66.8
 8.6 mm, respectively, in group 2). More than 40% of patients in both groups
had diabetes with equal distribution of insulin dependency.
Surgical Procedures
All patients had preoperative left ventriculography and echocardiogra-
phy for determination of LV volumes and diameters, as well as assessment
of mitral valve function and ejection fraction. Measurement of ejection frac-
tion was performed at stable hemodynamic conditions and only in the ab-
sence of moderate or severe mitral regurgitation. Still, afterload variations
might have interfered with the results. Parameters to identify patients suit-
able to surgical remodeling were as follows: an echocardiographic dyski-
netic or akinetic zone of at least 3 cm in diameter, ventricular dilatation
with LV end-diastolic diameter>55 mm, and LV thrombus.
All operations were performed by 4 senior surgeons using cardiopulmo-
nary bypass, tepid blood cardioplegia, and moderate systemic hypothermia
(30C–32C). Complete myocardial revascularization as allowed by the qual-
ity of coronary arteries with at least 1 arterial graft was performed in all
patients. A potentially resectable regional LV impairment was defined as
delineated zone of dyskinetic or akinetic anterior LV wall as a consequence664 The Journal of Thoracic and Cardiovascular Surof old myocardial infarction that displayed akinesis or diskinetic bulging as
seen in the preoperative angiography or echocardiography. Furthermore,
presences of LV mural thrombus as well as history of ventricular tachycardias
were further indications. More diffuse scarring without a clear border to the
surrounding myocardium was not defined as suitable for resection. In those
patients in whom a restoration procedure was performed, a delineated
zone of dyskinetic or akinetic anterior LV wall was intraoperatively identified
and opened. The nonfunctional myocardium was excised and reconstructed
using a modified Dor’s technique11 for large LV volumes (n¼ 64) or a mod-
ified Jatene’s technique12 for smaller aneurysms (n ¼ 56). As a first step,
a continuous 3-0 polypropylene purse-string suture placed at the border
between viable and scarred myocardium was used to constrict the distal
ventricular diameter, in most cases followed by direct closure using polytetra-
fluoroethylene-armed running suture. If the remodeled ventricular cavity was
expected to be too small with this technique, an additional pericardial patch
was used to remodel the LV apex. Care was taken to plicate a septal scar
when applicable. Subsequently, the mitral valve was approached (n ¼ 32 in
group 1 and n ¼ 34 in group 2). Mitral repair was performed in all cases of
mitral insufficiency greater than 2þ or annulus dilatation to a diameter of
more than 35 mm. Mitral annuloplasty was performed using undersized rings,
mostly either Carpentier Edwards Classic or Physio (Edwards LifeSciences,
Irvine, Calif). Only 2 valves in each group had to be replaced. If no contrain-
dication was identified, all patients received angiotensin-converting enzyme
inhibitors and beta-blockers postoperatively.
Follow-up
Data were collected retrospectively by means of questionnaires containing
the Minnesota Quality of Life Questionnaire13-15 mailed to the patients or
family practitioners and telephone interviews specifically addressing long-
term medication and procedure-related complications. Clinical and








Age (y) 70.5  9.8 68.3  9.76 NS
Males (n,%) 125 (76) 85 (71) NS
Chronic renal failure, n (%) 58 (35) 35 (29) NS
COPD, n (%) 58 (35) 27 (22.5) <.05
Systemic hypertension, n (%) 141 (85) 83 (69) <.05
Pulmonary hypertension, n (%) 38 (23) 18 (15) NS
Prior cerebrovascular
event, n (%)
13 (8) 17 (14) <.05
Morbid obesity, n (%) 38 (23) 20 (17) NS
Diabetes mellitus, n (%) 74 (45) 52 (43) NS
CCS class (mean  SD) 2.97  0.7 3.03  0.7 NS
CAD involvement (mean  SD) 2.8  0.5 2.6  0.7 NS
Myocardial infarction, n (%) 128 (78%) 100 (83%) NS
Anterior wall, n (%) 55 (33%) 51 (43%) <.05
Posterior wall, n (%) 62 (38%) 38 (32%) NS
Anterior and posterior
wall, n (%)
11 (7) 11 (9) NS
NYHA class (mean  SD) 3.2  0.6 3.1  0.6 NS
LVEF, mean  SD (%) 37.7  11.2 39.9  12.1 NS
LVEDD, mean  SD (mm) 57.1  7.3 59.8  8.6 NS
LVESVI (mL/m2) 84.2  16 92.3  22 NS
Moderate or severe
mitral regurgitation
32 (19) 14 (12) NS
COPD, Chronic obstructive pulmonary disease; CCS, Canadian Cardiovascular Soci-
ety; CAD, coronary artery disease; NYHA, New York Heart Association; LVEF, left
ventricular ejection fraction; LVEDD, left ventricular end-diastolic diameter; LVESVI,
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diologists were performed at 1 and 5 years after discharge. LVEF was calcu-
lated using the Simpson formula from biplane apical 4- and 2-chamber views.
Patients were followed for a total of 1615 patient-years. The mean clin-
ical follow-up was 68  5 months (range 48–84 months) and was 100%
complete.
Definitions and Data Analysis
Early mortality was defined as in hospital death within 30 days after the
operation; late mortality was defined as death after this period.
Low cardiac output syndrome was defined as heart index below 2.2 L $
min1 $ m2. Chronic renal failure was defined as structural or functional ab-
normalities of the kidney with decreased glomerular filtration rate (<60 mL
$ min1 $ 1.73m2), manifested by pathologic abnormalities or markers of
kidney damage, including abnormalities in the composition of the blood
or urine. Statistical analysis of the data was performed by using the Dal-
lal-Wilkinson corrected and Kolmogoroff-Smirnoff test.16 If this could be
verified due to small deviation of results, differences between both groups
were assessed by 2-sample t tests, the Mann-WhitneyU test, analysis of var-
iance, and multiple comparisons by Scheffe´ method with 95% confidence
limits.16 The commercially available statistical software BIAS, packaged
for Windows (Version 8.3.8, Epsilon-Verlag, Frankfurt am Main, Ger-
many), was used to perform the statistical analysis. Continuous data are
expressed as mean  standard deviation, unless indicated otherwise. Cate-
gorical data are expressed as frequencies.
Obesity was defined if the body mass index was equal or higher than 30.0
kg/m2.
Survival was estimated with the standard nonparametric Kaplan-Meier
method.17 Differences between survival curves were compared using the
Breslow test.18
RESULTS
Table 2 summarizes the operative results. The mean oper-
ating, cardiopulmonary bypass, and aortic crossclamp times









CABG (n) 133 (81%) 106 (88%) NS
CABGþvalve
replacement/repair (n)
32 (19%) 14 (12%) NS
Bypass grafts (n) 2.9  1.1 2.9  1.0 NS
Venous grafts (mean  SD) 2.2  0.9 2.1  0.8 NS
Arterial grafts (mean  SD) 1.12  0.5 1.15  0.5 NS
Operation time,
mean  SD (min)
200.2  73.8 214.7  69.4 NS
ECC time, mean  SD (min) 103.9  42.4 109.2  42.8 NS
Crossclamp time,
mean  SD (min)
59.3  28.6 63.2  28.4 NS
Cardioplegia
Calafiore, n (%) 114 (69%) 93 (78%) NS
Cold blood
cardioplegia, n (%)
53 (31%) 27 (22%) NS
Operative blood loss,
mean  SD (mL)
679.1  473.2 686.6  455.1 NS
Operative transfusion,
mean  SD (mL)
415.0  436.2 441.6  412.9 NS
CABG,Coronary artery bypass grafting;ECC, extracorporeal circulation; SD, standard
deviation; NS, not significant.The Journal of Thoracic and Cdid not significantly differ between the groups and averaged
to 200.2 73.8, 103.9 42.4, 59.3 28.6 minutes in group
1, respectively, and 214.7 69.4, 109.2 42.8, 63.2 28.4
minutes in group 2, respectively. LV end-systolic volume in-
dex was significantly lower in group 2 following the remod-
eling procedure.
Global systolic function improved early postoperatively.
LVEF increased by 4.7%  1.2% in surviving group 1 pa-
tients and by 9.7%  2.1% in those of group 2. This differ-
ence in LVEF increase demonstrated a trend in favor of
group 2 but failed to reach statistical significance (P ¼
.055). However, the addition of the LV restoration to the
myocardial revascularization led to significantly greater re-
duction of LV end-diastolic diameter as well as systolic
volume index in group 2 (Table 3, P< .05).
Group 2 patients had significantly longer ventilation
times, higher blood loss, and greater need for postoperative
blood transfusion (Table 3). The rate of rethoracotomy did
not differ between the groups. Five patients in each group
developed low cardiac output early postoperatively. The
number of patients with end-stage renal failure amounted
to 8 (5.2%) in group 1 and 7 (6.1%) in group 2. Operative
mortality was significantly lower in group 2 (4.5%) com-
pared with group 1 (8.5%, P< .05).
Follow-up
Figure 1 demonstrates the Kaplan-Meier survival curves
for a period of 7 years for the 2 groups comparing patients
with an age- and sex-matched German population. At 7
years’ follow-up, survival was 74.3%  8.1% in group 1
versus 84.2%  5.4% in group 2 (P< .001). Long-term







ICU time, mean (d) 3.2  5.6 3.9  7.9 NS
Ventilation time,
mean (min)
26.1  34.1 39.7  66.3 >.05
IABP insertion, n (%) 30 (18.2%) 22 (18.2%) NS
Blood loss postoperatively,
mean  SD (mL)
242.9  467.8 441.04  611.94 <.05
Transfusion postoperatively,
mean  SD (mL)
243.75 (317.68) 118.75 (233.33) >.05
Hospitalization time,
mean  SD (d)
11.7  8.6 12.8  9.3 NS
Serum creatinine,
mean  SD (mg/dL)
1.46  0.95 1.47  0.74 NS
Serum CK, mean  SD (U/L) 901.4  1547.0 750.1  791.14 NS
EF postoperatively (%) 42.1  5.6 48.1  7.3 NS
LVEDD, mean  SD (mm) 57.1  7.3 53.8  8.6 NS
LVESVI (mL/m2) 66.2  16 56.3  22 <.05
ICU, Intensive care unit; IABP, intra-aortic balloon pump; SD, standard deviation;
CK, creatinine kinase; EF, ejection fraction; LVEDD, left ventricular end-diastolic di-




Acquired Cardiovascular Disease Dzemali et alFIGURE 1. Survival curves of the 2 groups. Patients of group 2 (coronary artery bypass graftingþ left ventricular LV remodeling) demonstrated superior
survival compared with patients of group 1 (coronary artery bypass grafting alone).outcome of group 2 patients was equal to the matched popu-
lation (Figure 1). The differences of survival were signifi-
cantly lower for female compared to male patients
(Figure 2, A and B). Functional class and improvement of
exercise tolerance were significantly better for group 2
with mean of 1.7  0.7 than for group 1 with a mean of
2.03  0.8 (P< .05).
Overall quality of life assessed by the Minnesota Quality
of Life Questionnaire demonstrated a significantly better
quality of life for group 2 patients (13.2  13.4 vs 20.2 
18 points, P ¼ .0007; Figure 3).
The differences of Canadian Cardiovascular Society
were not significant for group 1 (1.1  4.1) and group 2
(1.2  4.4).
FIGURE 2. A and B, Survival curves of the 2 groups separated for gender. Both male and female patients showed improved midterm survival with a more
pronounced difference for female patients.
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Dzemali et al Acquired Cardiovascular DiseaseFIGURE 3. Quality of life (QoL) assessed by the Minnesota Quality of Life Questionnaire, which demonstrated a significantly better QoL for group 2
patients (G2 ¼ 13.2  13.4 vs G1 ¼ 20.2  18 points, P ¼ .0007). NYHA, New York Heart Association class.A
C
DLVEF increased further during follow-up in both groups,
with a significant difference in favor of group 1 (group 1¼
48.8%  7.4% and group 2 ¼ 58.9%  6.2%, P< .05).
Cardiac-related hospital readmissions (due to progres-
sive heart failure, progression of CAD, or arrhythmias)
were comparable (3.8% in group 1 vs 4.1% in group 2,
P ¼ .73).
DISCUSSION
In the current era of early interventional procedures for
acute myocardial infarctions with prompt opening of the cul-
prit lesion, thin-walled dyskinetic aneurysm formation has
become a less frequent infarct complication. Instead, the re-
sulting grossly akinetic segment retains its near-normal ap-
pearance and thickness but poses a long-lasting drive for
remote ventricular remodeling. Thus, surgeons nowadays
frequently see patients presenting with a moderately im-
paired LV composed of relatively modest akinetic zones
and localized dyskinetic areas or a combination of both. Sur-
vival in medically treated patients with ischemic cardiomy-
opathy is poor,19-21 so more aggressive strategies have been
promoted in the past decade. Indeed, outcome of surgically
treated patients was superior to previous conservative treat-
ment.22,23 The opinion among surgeons whether or not one
should attempt to restore a moderately impaired left ventricle
is controversial; many would leave the geometry undis-
turbed hoping for CABG alone to improve ventricular func-
tion.24,25 In this report, we attempted to address this issue
and observed the early and midterm outcomes following
operative revascularization alone versus LV restoration
combined with revascularization in patients with ischemic
cardiomyopathy and moderate LV dysfunction.
In our patient cohort, LV remodeling procedures were
more likely performed in patients with previous anterior
wall infarctions due to well-established operative techniques
described for this pathology.11,12 Such patients with rela-
tively modest LV dilatation had a modified Jatene procedure
in our institution, and those patients with markedly dilatedThe Journal of Thoracic and CLV would be considered candidates for a modified Dor pro-
cedure as described above. Ejection fraction did not differ
between the 2 groups and therefore did not predict LV re-
modeling operations. Although only 5 patients in each group
developed low cardiac output syndrome, an intra-aortic bal-
loon pump was inserted more frequently, as we liberally tend
to mechanically support those patients with borderline out-
put intraoperatively to avoid necessity for high doses of ino-
tropes. No complication from the application and use of
intra-aortic balloon counterpulsation was observed. In all
these patients, the balloon pump was sufficient to support
the circulation, and no further mechanical support was nec-
essary as patients with severely depressed LV function were
not included in the study. Regarding the inotrope support
regimen in our unit, milrinone has routinely been used as
a first-line inotrope, with the dosage adjusted according to
frequent measurements of cardiac output. Secondary drugs
were epinephrine and dobutamine. This regimen was not dif-
ferent between groups, so it could not account for the differ-
ences in operative mortality.
Significantly higher blood loss and greater need for trans-
fusion were seen after ventricular restoration procedures
without impairing the remaining postoperative outcome pa-
rameters, so the remodeling procedure did not add signifi-
cant morbidity. The operative mortality was higher than
usual in CABG operations. As the mortality was only
4.5% in the CABG-only procedures, this was partially ex-
plained by the high percentage of concomitant mitral proce-
dures. Also, comorbidities led to a mean preoperative
European System for Cardiac Operative Risk Evaluation
(EuroSCORE) of 8.2% in group 1 versus 7.9% in group 2
(difference not statistically significant), so the operative out-
come at least matched the patients’ risk profiles. Midterm
survival and quality of life demonstrated a clear benefit for
group 2. Complete revascularization alone exerts some
effect on reverse remodeling primarily by revitalizing
hibernating myocardium22; it is, however, the ventricular




Acquired Cardiovascular Disease Dzemali et alultimately improves survival. Those patients achieved a sur-
vival similar to that of a matched German population up to
the 7 years’ follow-up. On the other hand, female patients
having revascularization alone showed markedly inferior
results with less than 30% survival rates after 6 years.
Quality of life could be related to the improvement in
NYHA classification for both groups and also demonstrated
superior results for the patients following LV restoration
procedure. Therefore, our study strongly favors ventricular
remodeling operations in patients with moderately impaired
LV function, especially female patients, as they did not
improve sufficiently if the ventricular dysfunction was not
addressed.
During the study period, the impact of cardiac resynchro-
nization therapy in patients with bad ventricular function
having cardiac surgery was not established. Consecutively,
patients enrolled in this study were not subjected to such
therapy. Clearly, many of them would have been observed
as candidates for cardiac resynchronization and defibrillator
therapy according to the contemporary understanding of this
treatment modality.
Limitations of This Study
This is a nonrandomized, retrospective study of patients
who had surgical therapy for ischemic cardiomyopathy.
Ventricular geometry was probably different in the study
groups with predominance of defined akinetic or dyskinetic
areas in group 2. The outcome of patients with akinetic ver-
sus dyskinetic anterior walls was not analyzed separately, as
the patient files did not discriminate these 2 findings in all
cases. So no conclusion can be drawn as to whether patients
with dyskinetic areas behaved differently from those with
akinetic wall areas.
Our patients did not have coronary angiography postoper-
atively. Graft failure does influence LV remodeling unfavor-
ably and therefore the clinical outcomes after surgical
treatment for ischemic cardiomyopathy.
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